Terms: = Ovarian cancer AND FAM131B, Q86XD5, KIAA0773, 9715
2 results:
1. Low-dose-intensity bevacizumab with weekly irinotecan for platinum- and taxanes-resistant epithelial ovarian cancer.
Liu Y; Ren Z; Xu S; Bai H; Ma N; Wang F
Cancer Chemother Pharmacol; 2015 Mar; 75(3):645-51. PubMed ID: 25599660
[TBL] [Abstract] [Full Text] [Related]
2. Preparation, characterization, and antitumor activity of new cisplatin analogs with homopiperazines: crystal structure of [PtII(1-methylhomopiperazine)(methylmalonato)].2H2O.
Ali MS; Whitmire KH; Toyomasu T; Siddik ZH; Khokhar AR
J Inorg Biochem; 1999; 77(3-4):231-8. PubMed ID: 10643661
[TBL] [Abstract] [Full Text] [Related]
